Middle East & Africa Tissue Engineering Market Forecast to 2028 - COVID-19 Impact and Regional Analysis - by Material Type and Application

The tissue engineering market in Middle East & Africa is expected to grow from US$493.55 million in 2022 to US$ 954.80 million by 2028. It is estimated to grow at a CAGR of 9.9% from 2022 to 2028.

The rising chronic illness cases, increasing geriatric population, and surging pediatric care need are a few of the primary factors boosting the growth of the healthcare sector. The sector has been experiencing rapid transformation since the last couple of years. Various countries across the region use advanced technologies in healthcare. With an increase in the need for better healthcare facilities, technology-enabled care (TEC) solutions are in demand in the healthcare systems, especially in the emerging economies. As a result, various healthcare players are investing significant amounts of their revenues in R&D activities to develop advanced solutions, including stem cell products, and associated therapeutic technologies. Also, reimbursements provided for various medical procedures are likely to fuel the growth of this sector during the forecast period. The abovementioned factors are expected to generate growth opportunities for the tissue engineering market players during 2021-2028.

With new features and technologies, vendors can attract new customers and expand their footprints in emerging markets. This factor is likely to drive the Middle East & Africa tissue engineering market at a substantial CAGR during the forecast period.

Middle East & Africa Tissue Engineering Market Segmentation

The Middle East & Africa tissue engineering market is segmented on the basis of material type, application, and country.

• Based on material type, the market is segmented into biologically derived materials, synthetic materials, and others. In 2022, the biologically derived materials segment held the largest market share. However, the synthetic materials segment is expected to register the highest CAGR during the forecast period.
• Based on application, the market is segmented into orthopedic, musculoskeletal & spine, skin & integumentary, cardiology and vascular, neurology, cancer, gi & gynecology, urology, and others. In 2022, the orthopedic, musculoskeletal, & spine segment held the largest market share. However, the skin & integumentary segment is expected to register the highest CAGR in the market during the forecast period.
• Based on country, the Middle East & Africa tissue engineering market is segmented into the UAE, Saudi Arabia, South Africa, and Rest of MEA. In 2022, the UAE held the largest market share; and it is also expected to grow at the fastest CAGR during the forecast period.

Zimmer Biomet; B. Braun Melsungen AG; Stryker Corporation; AbbVie, Inc.; Integra LifeSciences Holdings Corporation; Medtronic; Baxter International Inc.; Johnson and Johnson Services, Inc.; 3M; and Cook Biotech Inc. are among the leading companies in the Middle East & Africa tissue engineering market.